Literature DB >> 17485526

Orf virus interleukin-10 inhibits cytokine synthesis in activated human THP-1 monocytes, but only partially impairs their proliferation.

Lyn Wise1, Catherine McCaughan, Chee Keong Tan, Andrew A Mercer, Stephen B Fleming.   

Abstract

The sheep parapoxvirus orf virus (ORFV) induces acute, pustular skin lesions in humans. ORFV encodes an orthologue of interleukin-10 (IL-10) that, whilst it closely resembles ovine IL-10 (91 % amino acid identity), shows only 75 % amino acid identity to human IL-10 (hIL-10). The anti-inflammatory potential of ORFV IL-10 in human ORFV infection was investigated by examining its immunosuppressive effects on THP-1 monocytes. ORFV IL-10 and hIL-10 were shown to have equivalent inhibitory effects on the synthesis of proinflammatory cytokines in lipopolysaccharide-activated monocytes, but differed in their abilities to inhibit monocyte proliferation. Structural modelling of ORFV IL-10 revealed differences from hIL-10 in residues predicted to interact with IL-10 co-receptor 2 (IL-10R2), whereas there were very few differences in the residues predicted to interact with IL-10R1. These findings suggest that the partial ability of ORFV IL-10 to inhibit THP-1 monocyte proliferation may be due to the absence of critical residues that mediate the interaction with human IL-10R2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485526     DOI: 10.1099/vir.0.82765-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

Review 1.  Virus-encoded homologs of cellular interleukin-10 and their control of host immune function.

Authors:  Barry Slobedman; Peter A Barry; Juliet V Spencer; Selmir Avdic; Allison Abendroth
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

Review 2.  Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures.

Authors:  Jan Felix; Savvas N Savvides
Journal:  Nat Rev Immunol       Date:  2016-12-28       Impact factor: 53.106

3.  Parapoxvirus Interleukin-10 Homologues Vary in Their Receptor Binding, Anti-Inflammatory, and Stimulatory Activities.

Authors:  Amreen Naqash; Gabriella Stuart; Roslyn Kemp; Lyn Wise
Journal:  Pathogens       Date:  2022-04-24

4.  Identification of novel viral interleukin-10 isoforms of human cytomegalovirus AD169.

Authors:  Yi-Ling Lin; Pei-Ching Chang; Yixiang Wang; Mengtao Li
Journal:  Virus Res       Date:  2007-11-05       Impact factor: 3.303

5.  Blocking the function of inflammatory cytokines and mediators by using IL-10 and TGF-β: a potential biological immunotherapy for intervertebral disc degeneration in a beagle model.

Authors:  Wei Li; Tianyi Liu; Liangliang Wu; Chun Chen; Zhiwei Jia; Xuedong Bai; Dike Ruan
Journal:  Int J Mol Sci       Date:  2014-09-26       Impact factor: 5.923

Review 6.  Molecular genetic analysis of orf virus: a poxvirus that has adapted to skin.

Authors:  Stephen B Fleming; Lyn M Wise; Andrew A Mercer
Journal:  Viruses       Date:  2015-03-23       Impact factor: 5.048

7.  A Broad-Spectrum Chemokine-Binding Protein of Bovine Papular Stomatitis Virus Inhibits Neutrophil and Monocyte Infiltration in Inflammatory and Wound Models of Mouse Skin.

Authors:  Saeed Sharif; Yoshio Nakatani; Lyn Wise; Michael Corbett; Nicola C Real; Gabriella S Stuart; Zabeen Lateef; Kurt Krause; Andrew A Mercer; Stephen B Fleming
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

8.  Orf Virus IL-10 and VEGF-E Act Synergistically to Enhance Healing of Cutaneous Wounds in Mice.

Authors:  Lyn M Wise; Gabriella S Stuart; Nicola C Jones; Stephen B Fleming; Andrew A Mercer
Journal:  J Clin Med       Date:  2020-04-11       Impact factor: 4.241

Review 9.  Deriving Immune Modulating Drugs from Viruses-A New Class of Biologics.

Authors:  Jordan R Yaron; Liqiang Zhang; Qiuyun Guo; Michelle Burgin; Lauren N Schutz; Enkidia Awo; Lyn Wise; Kurt L Krause; Cristhian J Ildefonso; Jacek M Kwiecien; Michael Juby; Masmudur M Rahman; Hao Chen; Richard W Moyer; Antonio Alcami; Grant McFadden; Alexandra R Lucas
Journal:  J Clin Med       Date:  2020-03-31       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.